CU6 2.32% $4.00 clarity pharmaceuticals ltd

Research/Valuation, page-176

  1. 1,913 Posts.
    lightbulb Created with Sketch. 316
    The possibility has been discussed, but I've only found two studies that have determined CKD risk.

    https://academic.oup.com/ckj/article/13/6/1049/5549858

    https://www.sciencedirect.com/science/article/abs/pii/S0302283822024010

    the second article has indicated that the cumulative dosage e was >50GBq for the 3 cases with renal damage.

    are there article of studies you can direct me to further to determine this?

    177lu dotate seems to have more risk?

    https://jnm.snmjournals.org/content/63/10/1503
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$4.00
Change
-0.095(2.32%)
Mkt cap ! $1.244B
Open High Low Value Volume
$4.10 $4.12 $3.96 $1.694M 422.4K

Buyers (Bids)

No. Vol. Price($)
5 2444 $3.99
 

Sellers (Offers)

Price($) Vol. No.
$4.00 17974 6
View Market Depth
Last trade - 11.39am 22/05/2024 (20 minute delay) ?
Last
$3.98
  Change
-0.095 ( 2.82 %)
Open High Low Volume
$4.12 $4.12 $3.96 18169
Last updated 11.55am 22/05/2024 ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.